NPR's Leila Fadel speaks with Dr. John Torous, director of digital psychiatry at Beth Israel Deaconess Medical Center in Boston, about the first app being approved to help treat depression. The Food ...

A shadow pandemic has accompanied COVID-19, one of deteriorating mental health. Formerly mundane acts, like buying groceries, now require a complete safety checklist as well as constant ...

John Torous, MD, MBI, providing expert testimony at the United States House Energy and Commerce Committee hearing on the risks and benefits of chatbots. Dr. Torous, who provided expert testimony at ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

John Torous, MD, MBI, is the director of the digital psychiatry division in the Department of Psychiatry at Beth Israel Deaconess Medical Center, a Harvard Medical School affiliated teaching hospital, ...

Symptoms of schizophrenia like hallucinations and paranoia can usually be improved with drugs and therapy. But things like anxiety, trouble with focus, and lack of motivation may not be as easy to ...

If you have ever sworn off social media for a week or two because you sensed it was feeding your anxiety or dampening your mood, you may be on to something. A new study out last week in JAMA Network ...

Moving forward requires focus. Mashable's Social Good Series is dedicated to exploring pathways to a greater good, spotlighting issues that are essential to making the world a better place. Finding ...

Thanks to the pandemic, there is heightened interest in new effective options for preventing and treating anxiety, depression, and other psychiatric illnesses. Human resources managers are looking for ...

This week, we got a trailer and a promise that in July, we'll get Pokemon Sleep. the game is "part virtual pet, part sleep tracking device." There is by now a vast ecosystem of media related to ...